Contrasting DNA damage checkpoint responses in epithelium of the human seminal vesicle and prostate

Prostate

Volumn 72, Issue 10, 2012, Pages 1060-1070

  Jäämaa, Sari ^a,b   Sankila, Anna ^c   Rantanen, Ville ^d   Peltonen, Karita ^a   Järvinen, Päivi M ^a   Af Hällström, Taija M ^a   Ruutu, Mirja ^c   Taari, Kimmo ^c   Andersson, Leif C ^a   Laiho, Marikki ^a,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

checkpoint; DNA damage; p53; prostate; Wee1A

Indexed keywords

ATM PROTEIN; HISTONE H2AX; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG; WEE1A CHECKPOINT KINASE;

ARTICLE; CELL CYCLE CHECKPOINT; CELL ISOLATION; CONTROLLED STUDY; DNA DAMAGE CHECKPOINT; EPITHELIUM CELL; EX VIVO STUDY; FLOW CYTOMETRY; GENOMIC INSTABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; MALE; MITOSIS; PHENOTYPE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN PHOSPHORYLATION; SECRETORY CELL; SEMINAL VESICLE; SIGNAL TRANSDUCTION; TISSUE CULTURE; TISSUE DIFFERENTIATION;

CELL CYCLE CHECKPOINTS; CELLS, CULTURED; DNA DAMAGE; EPITHELIAL CELLS; EPITHELIUM; HUMANS; MALE; PROSTATE; SEMINAL VESICLES;

EID: 84861572631     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21509     Document Type: Article

References (32)

1. Thiel R, Effert P,. Primary adenocarcinoma of the seminal vesicles. J Urol 2002; 168: 1891-1896.
2. Laczko I, Hudson DL, Freeman A, Feneley MR, Masters JR,. Comparison of the zones of the human prostate with the seminal vesicle: morphology, immunohistochemistry, and cell kinetics. Prostate 2005; 62: 260-266.
3. Thompson M, Lapointe J, Choi YL, Ong DE, Higgins JP, Brooks JD, Pollack JR,. Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle. Prostate 2008; 68: 1248-1256.
4. Yeh IT, Reddick RL, Kumar AP,. Malignancy arising in seminal vesicles in the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Prostate 2009; 69: 755-760.
5. Meyer KM, Hess SM, Tlsty TD, Leadon SA,. Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light. Oncogene 1999; 18: 5795-5805.
6. Gadbois DM, Lehnert BE,. Cell cycle response to DNA damage differs in bronchial epithelial cells and lung fibroblasts. Cancer Res 1997; 57: 3174-3179.
7. Flatt PM, Price JO, Shaw A, Pietenpol JA,. Differential cell cycle checkpoint response in normal human keratinocytes and fibroblasts. Cell Growth Differ 1998; 9: 535-543.
8. Girinsky T, Koumenis C, Graeber TG, Peehl DM, Giaccia AJ,. Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents. Cancer Res 1995; 55: 3726-3731.
9. Kiviharju-af Hällström TM, Jäämaa S, Mönkkönen M, Peltonen K, Andersson LC, Medema RH, Peehl DM, Laiho M,. Human prostate epithelium lacks Wee1A-mediated DNA damage-induced checkpoint enforcement. Proc Natl Acad Sci USA 2007; 104: 7211-7216.
10. Jäämaa S, af Hällström TM, Sankila A, Rantanen V, Koistinen H, Stenman UH, Zhang Z, Yang Z, De Marzo AM, Taari K, Ruutu M, Andersson LC, Laiho M,. DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue. Cancer Res 2010; 70: 8630-8641.
11. Zhang Z, Yang Z, Jäämaa S, Liu H, Pellakuru LG, Iwata T, af Hällström TM, De Marzo AM, Laiho M,. Differential epithelium DNA damage response to ATM and DNA-PK pathway inhibition in human prostate tissue culture. Cell Cycle 2011; 10: 3545-3553.
12. Leroy X, Ballereau C, Villers A, Saint F, Aubert S, Gosselin B, Porchet N, Copin MC,. MUC6 is a marker of seminal vesicle-ejaculatory duct epithelium and is useful for the differential diagnosis with prostate adenocarcinoma. Am J Surg Pathol 2003; 27: 519-521.
13. FitzGerald JE, Grenon M, Lowndes NF,. 53BP1: function and mechanisms of focal recruitment. Biochem Soc Trans 2009; 37: 897-904.
14. Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y,. GammaH2AX and cancer. Nat Rev Cancer 2008; 8: 957-967.
15. Celeste A, Difilippantonio S, Difilippantonio MJ, Fernandez-Capetillo O, Pilch DR, Sedelnikova OA, Eckhaus M, Ried T, Bonner WM, Nussenzweig A,. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 2003; 114: 371-383.
16. Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E, Difilippantonio MJ, Redon C, Pilch DR, Olaru A, Eckhaus M, Camerini-Otero RD, Tessarollo L, Livak F, Manova K, Bonner WM, Nussenzweig MC, Nussenzweig A,. Genomic instability in mice lacking histone H2AX. Science 2002; 296: 922-927.
17. Zilfou JT, Lowe SW,. Tumor suppressive functions of p53. Cold Spring Harb. Perspect Biol 2009; 1: a001883.
18. Huper G, Marks JR,. Isogenic normal basal and luminal mammary epithelial isolated by a novel method show a differential response to ionizing radiation. Cancer Res 2007; 67: 2990-3001.
19. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW,. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-6311.
20. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB,. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992; 89: 7491-7495.
21. Yuan H, Xie YM, Chen IS,. Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis. J Virol 2003; 77: 2063-2070.
22. Tominaga Y, Li C, Wang RH, Deng CX,. Murine Wee1 plays a critical role in cell cycle regulation and pre-implantation stages of embryonic development. Int J Biol Sci 2006; 2: 161-170.
23. Beck H, Nahse V, Larsen MS, Groth P, Clancy T, Lees M, Jorgensen M, Helleday T, Syljuasen RG, Sorensen CS,. Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase. J Cell Biol 2010; 188: 629-638.
24. Coates PJ, Appleyard MV, Murray K, Ackland C, Gardner J, Brown DC, Adamson DJ, Jordan LB, Purdie CA, Munro AJ, Wright EG, Dewar JA, Thompson AM,. Differential contextual responses of normal human breast epithelium to ionizing radiation in a mouse xenograft model. Cancer Res 2010; 70: 9808-9815.
25. Levanon K, Ng V, Piao HY, Zhang Y, Chang MC, Roh MH, Kindelberger DW, Hirsch MS, Crum CP, Marto JA, Drapkin R,. Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 2010; 29: 1103-1113.
26. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH,. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849-852.
27. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T,. P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362: 847-849.
28. Gudkov AV, Komarova EA,. The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 2003; 3: 117-129.
29. Hällström TM, Laiho M,. Genetic changes and DNA damage responses in the prostate. Prostate 2008; 68: 902-918.
30. Al Rashid ST, Dellaire G, Cuddihy A, Jalali F, Vaid M, Coackley C, Folkard M, Xu Y, Chen BP, Chen DJ, Lilge L, Prise KM, Bazett Jones DP, Bristow RG,. Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo. Cancer Res 2005; 65: 10810-10821.
31. Nouspikel T,. DNA repair in differentiated cells: some new answers to old questions. Neuroscience 2007; 145: 1213-1221.
32. Fortini P, Dogliotti E,. Mechanisms of dealing with DNA damage in terminally differentiated cells. Mutat Res 2010; 685: 38-44.